Martínez LSZ, Alcántara PGA, García MJM, Becerril PM, Cruz HA

Language: Spanish
References: 10
Page: 538-542
PDF size: 444.78 Kb.

ABSTRACT

Introduction: avascular necrosis (AVN) of the hip is a degenerative condition resulting from alterations in the intraosseous blood supply. Since the COVID-19 pandemic and the widespread use of corticosteroids, an increase in AVN cases has been observed, even among patients without previous risk factors. Proposed mechanisms include systemic inflammation, vasculitis, and hypercoagulability. This situation has raised concern regarding the relationship between steroid therapy and the development of AVN, making it necessary to study this association in the Mexican population. Material and methods: between January 2020 and June 2025, 11 patients with hip AVN were studied at Hospital Angeles Mocel. Results: a total of 81.8% had a history of COVID-19, and 72.7% received corticosteroids. Unilateral involvement predominated, mainly grade II–III, with an average symptom onset of 12 months post-COVID; 54.5% underwent total hip arthroplasty and 27.3% underwent core decompression. Conclusion: a significant association (p‹ 0.028) was found between a history of COVID-19 and the development of hip AVN in patients treated with corticosteroids. Clinical and radiological follow-up during the first year post-infection is recommended.

REFERENCES

1. Parikh S, Gomez O, Davis T, Lyon Z, Corces A. Avascular necrosis asa sequela of COVID-19: a case series. Cureus. 2023; 15 (2): e35368.doi: 10.7759/cureus.35368.

2. Sinha PR, Mallick N, Sahu RL. Avascular necrosis of the hip afterthe COVID-19 pandemic. J Pharm Bioallied Sci. 2023; 15 (Suppl 1):S661-S664. doi: 10.4103/jpbs.jpbs_87_23.

3. Sakellariou E, Argyropoulou E, Karampinas P, Galanis A, Varsamos I,Giannatos V et al. A Comprehensive review of COVID-19-infection- andsteroid-treatment-associated bone avascular necrosis: a multi-study analysis.Diagnostics (Basel). 2024; 14 (3): 247. doi: 10.3390/diagnostics14030247.

4. Shetty GM. Double trouble-COVID-19 and the widespread use ofcorticosteroids: are we staring at an osteonecrosis epidemic? Indian JOrthop. 2021; 56 (2): 226-236. doi: 10.1007/s43465-021-00546-8.

5. Hassan AAA, Khalifa AA. Femoral head avascular necrosis inCOVID-19 survivors: a systematic review. Rheumatol Int. 2023; 43(9): 1583-1595. doi: 10.1007/s00296-023-05373-8.

6. Murugesan L, Sivakumar N, Ramamoorthy L, Farooq U. COVID-19-associated bilateral avascular necrosis of femoral head in a youngmale without corticosteroid exposure: a case report. Cureus. 2024;16 (4): e57525. doi: 10.7759/cureus.57525.

7. Chang C, Greenspan A, Gershwin ME. The pathogenesis, diagnosisand clinical manifestations of steroid-induced osteonecrosis. JAutoimmun. 2020; 110: 102460. doi: 10.1016/j.jaut.2020.102460.

8. Veizi E, Erdogan Y, Sezgin BS, Karaman Y, Kilicarslan K, Firat A. Thepainful joint after COVID-19 treatment: a study on joint osteonecrosisfollowing COVID-19-related corticosteroid use. Jt Dis Relat Surg.2023; 34 (1): 75-83. doi: 10.52312/jdrs.2023.895.

9. Annam P, Manda A, Myneni UK, Sahar AN, Prasad N, Sam KK et al.Corticosteroids induced avascular necrosis of hip, a “long COVID-19”complication: case report. Ann Med Surg (Lond). 2022; 82: 104753.doi: 10.1016/j.amsu.2022.104753.

10. Migliorini F, Maffulli N, Shukla T, D’Ambrosi R, Singla M, Vaish Aet al. The pandemic is gone but its consequences are here to stay:avascular necrosis following corticosteroids administration for severeCOVID-19. J Orthop Surg Res. 2024; 19 (1): 135.